effects [qlco]
High dose [qnco]
atorvastatin [orch, phsu]
Anti-inflammatory [phsu]
properties [qlco]
High [qlco]
density [qnco]
Lipoprotein [aapp, bacs]
Patients [podg]
Rheumatoid Arthritis [dsyn]
atorvastatin [orch, phsu]
Pilot Study [resa]
Objective [inpr]
Patients [podg]
Rheumatoid Arthritis [dsyn]
Fold [spco]
Increased [qnco]
Risk [qlco]
Myocardial Infarction [dsyn]
Recent [tmco]
Work [ocac]
Suggest [idcn]
Plasma [bdsu]
High Density Lipoproteins [aapp, bacs, lipd]
Patients [podg]
Rheumatoid Arthritis [dsyn]
More [ftcn]
High Density Lipoproteins [aapp, bacs, lipd]
Control [grup]
Examined [fndg]
effects [qlco]
Daily [tmco]
Inflammatory [ftcn]
properties [qlco]
High Density Lipoproteins [aapp, bacs, lipd]
Clinical [qlco]
Disease [dsyn]
activity [dora]
Rheumatoid Arthritis [dsyn]
Methods [inpr]
twenty [orch, phsu]
Subject [grup]
Active [ftcn]
Rheumatoid Arthritis [dsyn]
Mean score [qnco]
Disease [dsyn]
activity [dora]
Dyslipidaemia [dsyn]
History [ocdi]
coronary artery disease [dsyn]
randomized [resa]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Trial [resa]
Receive [qlco]
mg% [qnco]
atorvastatin [orch, phsu]
placebo [topp]
Daily [tmco]
Stable [qlco]
Drug Therapy [topp]
Disease [dsyn]
activity [dora]
variables [qlco]
weeks [tmco]
properties [qlco]
High Density Lipoproteins [aapp, bacs, lipd]
BY [geoa]
cell free [cell]
Assay [lbpr]
Measure [qnco]
lipid oxidation [moft]
Products [enty]
Result [ftcn]
weeks [tmco]
Subject [grup]
Complete [qlco]
atorvastatin [orch, phsu]
Protocol [inpr]
Mean [qnco]
reduction [npop]
cell free [cell]
Assay [lbpr]
Values [qlco]
Subject [grup]
Complete [qlco]
placebo [topp]
Protocol [inpr]
Mean [qnco]
Increase [ftcn]
cell free [cell]
Assay [lbpr]
Values [qlco]
P NOS [aapp, imft]
trend [tmco]
Decrease [qlco]
Highly sensitive [qlco]
C-reactive protein [aapp, imft]
weeks [tmco]
atorvastatin [orch, phsu]
Group [idcn]
Compared [acty]
Increase [ftcn]
Highly sensitive [qlco]
C-reactive protein [aapp, imft]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
Change [ftcn]
Measures [qnco]
Clinical [qlco]
Disease [dsyn]
activity [dora]
Plasma [bdsu]
cytokine [aapp, imft]
Levels [qlco]
Not [ftcn]
Different [qlco]
atorvastatin [orch, phsu]
placebo [topp]
Group [idcn]
Conclusion [idcn]
Patients [podg]
Active [ftcn]
Rheumatoid Arthritis [dsyn]
High Density Lipoproteins [aapp, bacs, lipd]
More [ftcn]
Anti-inflammatory [phsu]
High dose [qnco]
atorvastatin [orch, phsu]
Compared [acty]
placebo [topp]
Functional [ftcn]
Characterization [acty]
High Density Lipoproteins [aapp, bacs, lipd]
Further [spco]
Investigation [hlca]
Method [inpr]
CARDIOVASCULAR [bdsy]
Risk Assessment [hlca]
Rheumatoid Arthritis [dsyn]
Patients [podg]
Traditional [ftcn]
coronary [bpoc]
risk factors [qnco]
